Source: Eur Respir Rev, 26 (144) 170002; 10.1183/16000617.0002-2017



Rating:

Share or cite this content

Citations should be made in the following way:
Simon L.F. Walsh. Multidisciplinary evaluation of interstitial lung diseases: current insights. Eur Respir Rev, 26 (144) 170002; 10.1183/16000617.0002-2017

Member's Comments

No comment yet.

Related content which might interest you: Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence Source: Eur Respir Rev, 27 (150) 180074; 10.1183/16000617.0074-2018 Year: 2018 Treatment of interstitial lung diseases: current approaches and future directions Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 Clinical management implications of histologic information provided by lung biopsy in the multidisciplinary evaluation of interstitial lung diseases. Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology Year: 2020 Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 Clinical management of the idiopathic interstitial pneumonias: an example of an integrated approach to interstitial lung diseases Source: Annual Congress 2006 - PG8 - Interstitial lung diseases: idiopathic interstitial pneumonias Year: 2006 Interstitial lung diseases: a clinical update Source: Eur Respir J 2001; 18: 1S Year: 2001 Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 48-56 Year: 2012 Multidisciplinary board for interstitial lung disease: Relevance for real life? Source: International Congress 2015 – New insights into IIPs Year: 2015 Diagnosis of interstitial lung diseases and impact of guidelines: an issue only for pulmonologists? Source: Annual Congress 2007 - Controversies in the management of interstitial lung diseases Year: 2007 Latest insights into treatment of small airways diseases Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD Year: 2019 Interstitial lung disease: new challenges and evolving phenotypes Source: Eur Respir Rev 2009; 19: 91-93 Year: 2010 Diffuse parenchymal lung disease: a practical overview Is a lung biopsy necessary for management? Source: Breathe 2008; 4: 233-239 Year: 2008 A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease Source: Eur Respir J, 58 (6) 2100276; 10.1183/13993003.00276-2021 Year: 2021 Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases) Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective Source: International Congress 2019 – Rare lung diseases Year: 2019 Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019 Year: 2019 New concepts in diffuse interstitial lung diseases Source: Annual Congress 2008 - Clinical year in review Year: 2008 Multidisciplinary diagnosis of interstitial lung disease: a retrospective analysis Source: International Congress 2019 – Medical education Year: 2019 Early origins of lung disease: towards an interdisciplinary approach Source: Eur Respir Rev, 29 (157) 200191; 10.1183/16000617.0191-2020 Year: 2020 The genetics of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190053; 10.1183/16000617.0053-2019 Year: 2019